Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, Epiciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

Le virus de la stomatite vésiculaire dans la lutte contre le cancer

Abstract : Cancer is a complex disease that affects more and more people around the world. Unfortunately, existing treatments are only partially efficient and often induce major side effects. Thus, the use of viruses to selectively kill cancer cells is a new promising therapeutic approach. Recently, VSV has been used in oncolytic virotherapy because of its capacity to preferentially infect most human tumor cells. However, despite the availability of good oncolytic VSV mutants, the large variability of tumor cell types and the multiple ways in which they can evade viral infection suggests that therapeutic combinations of various viruses will be necessary to efficiently treat most cancers. A better understanding of the infection mechanisms and immune system recruitment by oncolytic viruses will be of great value for the development of safe and efficient strategies for cancer treatment.
Complete list of metadata

Cited literature [57 references]  Display  Hide  Download
Contributor : Michel Courcelles Connect in order to contact the contributor
Submitted on : Thursday, March 12, 2015 - 8:01:28 PM
Last modification on : Monday, February 14, 2022 - 10:20:12 AM
Long-term archiving on: : Saturday, June 13, 2015 - 12:11:16 PM


Publisher files allowed on an open archive




Valérie Janelle, Laurent Poliquin, Alain Lamarre. Le virus de la stomatite vésiculaire dans la lutte contre le cancer. médecine/sciences, EDP Sciences, 2013, 29 (2), pp.175-82. ⟨10.1051/medsci/2013292015⟩. ⟨pasteur-01131063⟩



Record views


Files downloads